Clinical trial
Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients…
NCT00018083 · National Center for Research Resources (NCRR), NIH · Unknown status
Key facts
| NCT number | NCT00018083 |
|---|---|
| Title | Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen |
| Official title | Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen |
| Lead sponsor | National Center for Research Resources (NCRR), NIH |
| Collaborators | Centers for Disease Control and Prevention U.S. Fed |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Tuberculosis, HIV Infections |
| Intervention type | Drug |
| Interventions | rifabutin, isoniazid, efavirenz |
| First posted | Jul 4, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: